CDT EQUITY INC. Capital Expenditures
CDT EQUITY INC. (CDT) reported Capital Expenditures of $405.00 thousand for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2025-08-14
- CDT EQUITY INC. payments to acquire property, plant, and equipment for the quarter ending 2025-06-30 was $1.00K.
- CDT EQUITY INC. payments to acquire property, plant, and equipment for the quarter ending 2025-03-31 was $404.00K.
- CDT EQUITY INC. payments to acquire property, plant, and equipment for the quarter ending 2024-12-31 was $0.00.
- CDT EQUITY INC. payments to acquire property, plant, and equipment for the quarter ending 2024-09-30 was $41.00K.
- CDT EQUITY INC. payments to acquire property, plant, and equipment for fiscal 2024 was $51.00K.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 3 month as first filed | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|---|
| 2025-06-30 | $1.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2025-08-14 | $405.00K 10-Q · filed 2025-08-14 | $405.00K derived: sum of 3 quarters · filed 2025-08-14 | $446.00K derived: sum of 4 quarters · filed 2025-08-14 | |
| 2025-03-31 | $404.00K 10-Q/A · filed 2025-08-14 | $4.00K 10-Q · filed 2025-05-15 | $404.00K derived: sum of 2 quarters · filed 2025-08-14 | $445.00K derived: sum of 3 quarters · filed 2025-08-14 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $41.00K derived: sum of 2 quarters · filed 2025-03-28 | $51.00K 10-K · filed 2025-03-28 | ||
| 2024-09-30 | $41.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $51.00K 10-Q · filed 2024-11-14 | |||
| 2024-06-30 | $10.00K 10-Q · filed 2025-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |